These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer. Stein JP; Skinner DG BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375 [No Abstract] [Full Text] [Related]
44. Re: impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy: R. D. Da silva, e. Xylinas, L. Kluth, j. J. Crivelli, j. Chrystal, d. Chade, g. B. Guglielmetti, a. Pycha, y. Lotan, p. I. Karakiewicz, m. Sun, h. Fajkovic, m. Zerbib, d. S. Scherr and s. F. Shariat j urol 2013; 190: 487-492. Atmaca AF J Urol; 2014 Jan; 191(1):273. PubMed ID: 24139793 [No Abstract] [Full Text] [Related]
45. Re: Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy: R. D. da Silva, E. Xylinas, L. Kluth, J. J. Crivelli, J. Chrystal, D. Chade, G. B. Guglielmetti, A. Pycha, Y. Lotan, P. I. Karakiewicz, M. Sun, H. Fajkovic, M. Zerbib, D. S. Scherr and S. F. Shariat J Urol 2013;190:487-492. Ozgur BC; Sarici H; Yuceturk CN J Urol; 2014 Aug; 192(2):618-9. PubMed ID: 24792987 [No Abstract] [Full Text] [Related]
46. Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. Tollefson MK; Blute ML; Farmer SA; Frank I J Urol; 2010 Jan; 183(1):81-6. PubMed ID: 19913820 [TBL] [Abstract][Full Text] [Related]
47. The importance of surgical margins in renal cell and urothelial carcinomas. Alemozaffar M; Filson CP; Master VA J Surg Oncol; 2016 Mar; 113(3):316-22. PubMed ID: 26936428 [TBL] [Abstract][Full Text] [Related]
48. Transitional cell carcinoma of the upper urinary tract after cystectomy. Huguet J Arch Esp Urol; 2012 Mar; 65(2):227-36. PubMed ID: 22414451 [TBL] [Abstract][Full Text] [Related]
49. Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy. Nakagawa T; Hara T; Kawahara T; Ogata Y; Nakanishi H; Komiyama M; Arai E; Kanai Y; Fujimoto H J Urol; 2013 Apr; 189(4):1275-81. PubMed ID: 23123368 [TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771 [TBL] [Abstract][Full Text] [Related]
51. Re: Stenting Prior to Cystectomy Is an Independent Risk Factor for Upper Urinary Tract Recurrence. Giannarini G; Crestani A; Ficarra V Eur Urol; 2018 Sep; 74(3):395-396. PubMed ID: 29685643 [No Abstract] [Full Text] [Related]
52. [Transitional cell carcinoma of the upper urinary tract following total cystectomy for bladder cancer]. Hayashi Y; Tawada T; Ando Y Hinyokika Kiyo; 1992 Sep; 38(9):1015-8; discussion 1018-9. PubMed ID: 1414752 [TBL] [Abstract][Full Text] [Related]
53. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer. Sivalingam S; Probert JL; Schwaibold H BJU Int; 2005 Oct; 96(6):759-62. PubMed ID: 16153194 [No Abstract] [Full Text] [Related]
54. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. Gakis G BJU Int; 2013 Feb; 111(2):186-7. PubMed ID: 22928948 [No Abstract] [Full Text] [Related]
55. Re: Factors Influencing the Length of Stay after Radical Cystectomy: Implications for Cancer Care and Perioperative Management. Chang SS J Urol; 2016 Mar; 195(3):610. PubMed ID: 26887705 [No Abstract] [Full Text] [Related]
56. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder. Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019 [TBL] [Abstract][Full Text] [Related]
57. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [TBL] [Abstract][Full Text] [Related]
58. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213 [TBL] [Abstract][Full Text] [Related]
59. Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion. Chen H; Liu L; Pambuccian SE; Barkan GA; Quek ML; Wojcik EM Cancer Cytopathol; 2016 Apr; 124(4):273-8. PubMed ID: 26566001 [TBL] [Abstract][Full Text] [Related]
60. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]